Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 2Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Sleep Apnea, Obstructive 1Metabolic Syndrome 1Insulin Resistance 1Glucose Intolerance 1

Interventions

Metformin 7Clomiphene 4Progesterone 2Pioglitazone 2Medroxyprogesterone Acetate 2Inositol 2Folic Acid 2Flutamide 2Estrogens 2Estradiol 2salicylsalicylic acid 1ganirelix 1Thioctic Acid 1Sugars 1Resistance Training 1Raloxifene Hydrochloride 1Progestins 1Nutrition Assessment 1Methyltestosterone 1Magnesium 1Linseed Oil 1Leuprolide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Gonadotropins 1Flour 1Fenofibrate 1Exercise 1Docosahexaenoic Acids 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Polycystic Ovary Syndrome × Estrogens × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

NCT01428245 2020-12-30

JCM026

University of Virginia

Phase NA Terminated
3 enrolled 4 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡